Status:

COMPLETED

Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease

Lead Sponsor:

Indiana University

Conditions:

Infant, Premature

Bronchopulmonary Dysplasia

Eligibility:

All Genders

2-2 years

Brief Summary

The purpose of this study is to evaluate how easily gas can be taken up by the lung. We are comparing infants born premature \<32 weeks gestation to infants born full term \>37 weeks. We hope to evalu...

Detailed Description

We hypothesize that infants who were born prematurely but are clinically without chronic respiratory disease have a lower lung diffusion capacity than healthy infants born at full term, when evaluated...

Eligibility Criteria

Inclusion

  • Group 1 Infants born at \< 32 weeks gestation with Chronic lung disease
  • Group 2 Infants born at \<32 weeks gestation without Chronic lung disease
  • Group 3 Infants born full term at \>37 weeks

Exclusion

  • Group 1 and Group 2--No heart disease, no oxygen requirement
  • Group 3--No hospitalization for respiratory illness, No asthma, No heart disease, No history of wheezing, asthma or treatment with asthma medications.

Key Trial Info

Start Date :

February 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT00428038

Start Date

February 1 2004

End Date

December 1 2008

Last Update

March 30 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Riley Hospital for Children

Indianapolis, Indiana, United States, 46202

Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease | DecenTrialz